117 related articles for article (PubMed ID: 27069137)
1. Long Non-coding RNA, PANDA, Contributes to the Stabilization of p53 Tumor Suppressor Protein.
Kotake Y; Kitagawa K; Ohhata T; Sakai S; Uchida C; Niida H; Naemura M; Kitagawa M
Anticancer Res; 2016 Apr; 36(4):1605-11. PubMed ID: 27069137
[TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA PANDA Positively Regulates Proliferation of Osteosarcoma Cells.
Kotake Y; Goto T; Naemura M; Inoue Y; Okamoto H; Tahara K
Anticancer Res; 2017 Jan; 37(1):81-85. PubMed ID: 28011477
[TBL] [Abstract][Full Text] [Related]
3. p53-dependent non-coding RNA networks in chronic lymphocytic leukemia.
Blume CJ; Hotz-Wagenblatt A; Hüllein J; Sellner L; Jethwa A; Stolz T; Slabicki M; Lee K; Sharathchandra A; Benner A; Dietrich S; Oakes CC; Dreger P; te Raa D; Kater AP; Jauch A; Merkel O; Oren M; Hielscher T; Zenz T
Leukemia; 2015 Oct; 29(10):2015-23. PubMed ID: 25971364
[TBL] [Abstract][Full Text] [Related]
4. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
5. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
[TBL] [Abstract][Full Text] [Related]
6. DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter.
Liu H; Hew HC; Lu ZG; Yamaguchi T; Miki Y; Yoshida K
Biochem J; 2009 Aug; 422(3):543-51. PubMed ID: 19558368
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory role of E2F-1 in the regulation of tumor suppressor p53 during DNA damage response.
Yoshihara Y; Wu D; Kubo N; Sang M; Nakagawara A; Ozaki T
Biochem Biophys Res Commun; 2012 Apr; 421(1):57-63. PubMed ID: 22480684
[TBL] [Abstract][Full Text] [Related]
8. p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells.
Ruiz-Ruiz MC; López-Rivas A
Cell Death Differ; 1999 Mar; 6(3):271-80. PubMed ID: 10200578
[TBL] [Abstract][Full Text] [Related]
9. Selenoprotein W depletion induces a p53- and p21-dependent delay in cell cycle progression in RWPE-1 prostate epithelial cells.
Hawkes WC; Printsev I; Alkan Z
J Cell Biochem; 2012 Jan; 113(1):61-9. PubMed ID: 21866568
[TBL] [Abstract][Full Text] [Related]
10. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
Di Stefano V; Soddu S; Sacchi A; D'Orazi G
Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
[TBL] [Abstract][Full Text] [Related]
11. LincRNA-p21 acts as a mediator of ING1b-induced apoptosis.
Tran UM; Rajarajacholan U; Soh J; Kim TS; Thalappilly S; Sensen CW; Riabowol K
Cell Death Dis; 2015 Mar; 6(3):e1668. PubMed ID: 25741593
[TBL] [Abstract][Full Text] [Related]
12. Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-beta1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes.
Solá S; Castro RE; Kren BT; Steer CJ; Rodrigues CM
Biochemistry; 2004 Jul; 43(26):8429-38. PubMed ID: 15222754
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of survivin and upregulation of p53 gene expression by small interfering RNA induces apoptosis in human gastric carcinoma cell line SGC-823.
Lu YH; Wang K; He R; Xi T
Cancer Biother Radiopharm; 2008 Dec; 23(6):727-34. PubMed ID: 19111044
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs.
Koivusalo R; Krausz E; Helenius H; Hietanen S
Mol Pharmacol; 2005 Aug; 68(2):372-82. PubMed ID: 15908516
[TBL] [Abstract][Full Text] [Related]
15. Activation of the transcription factor Oct-1 in response to DNA damage.
Zhao H; Jin S; Fan F; Fan W; Tong T; Zhan Q
Cancer Res; 2000 Nov; 60(22):6276-80. PubMed ID: 11103783
[TBL] [Abstract][Full Text] [Related]
16. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
Phan RT; Dalla-Favera R
Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
[TBL] [Abstract][Full Text] [Related]
17. Role for Kruppel-like factor 4 in determining the outcome of p53 response to DNA damage.
Zhou Q; Hong Y; Zhan Q; Shen Y; Liu Z
Cancer Res; 2009 Nov; 69(21):8284-92. PubMed ID: 19826046
[TBL] [Abstract][Full Text] [Related]
18. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.
Liu X; Yue P; Khuri FR; Sun SY
Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375
[TBL] [Abstract][Full Text] [Related]
19. BaP-induced DNA damage initiated p53-independent necroptosis via the mitochondrial pathway involving Bax and Bcl-2.
Jiang Y; Chen X; Yang G; Wang Q; Wang J; Xiong W; Yuan J
Hum Exp Toxicol; 2013 Dec; 32(12):1245-57. PubMed ID: 23703817
[TBL] [Abstract][Full Text] [Related]
20. c-ABL tyrosine kinase modulates p53-dependent p21 induction and ensuing cell fate decision in response to DNA damage.
Udden SM; Morita-Fujimura Y; Satake M; Ikawa S
Cell Signal; 2014 Feb; 26(2):444-52. PubMed ID: 24177958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
